SequelSEC

INTUITIVE SURGICAL INC ISRG

Orthopedic, Prosthetic & Surgical Appliances & Supplies · CIK 0001035267 · Fiscal year ends 1231

Revenue
$10.06B
Fiscal year ended 2025-12-31
Operating income
$2.95B
Fiscal year ended 2025-12-31
Free cash flow
Unavailable
Fiscal year ended 2025-12-31

INTUITIVE SURGICAL INC (ISRG) reported revenue of $10.06B and net income of $2.86B for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from INTUITIVE SURGICAL INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Orthopedic, Prosthetic & Surgical Appliances & Supplies.

Income

INTUITIVE SURGICAL INC income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$10.06B$8.35B$7.12B$6.22B$5.71B$4.36B$4.48B$3.72B$3.14B$2.71B
Cost of revenue$3.42B$2.72B$2.39B$2.03B$1.75B$1.50B$1.37B$1.12B$936.20M$813.60M
Gross profit$6.64B$5.63B$4.73B$4.20B$3.96B$2.86B$3.11B$2.60B$2.20B$1.89B
Operating income$2.95B$2.35B$1.77B$1.58B$1.82B$1.05B$1.37B$1.20B$1.06B$949.70M
Net income$2.86B$2.32B$1.80B$1.32B$1.70B$1.06B$1.38B$1.13B$670.90M$738.30M
Research & development$1.31B$1.15B$998.80M$879.00M$671.00M$595.10M$557.30M$418.10M$328.60M$239.60M
Weighted-average diluted sharesshares 362.70Mshares 362.00Mshares 357.40Mshares 362.00Mshares 365.80Mshares 361.00Mshares 358.40Mshares 118.80Mshares 116.30Mshares 117.90M
Pretax income$3.31B$2.67B$1.96B$1.61B$1.89B$1.21B$1.50B$1.28B$1.10B$985.30M
Income tax expense$434.80M$336.30M$141.60M$262.40M$162.20M$140.20M$120.40M$154.50M$433.90M$247.00M
Diluted EPS$7.87$6.42$5.03$3.65$4.66$2.94$3.85$9.49$5.77$6.26
Selling, general & administrative$2.38B$2.14B$1.96B$1.74B$1.47B$1.22B$1.18B$986.60M$810.50M$703.60M
General & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

INTUITIVE SURGICAL INC balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Cash & equivalents$3.37B$2.03B$2.75B$1.58B$1.29B$1.62B$1.17B$857.90M$648.20M$1.04B
Total assets$20.46B$18.74B$15.44B$12.97B$13.56B$11.17B$9.73B$7.85B$5.78B$6.49B
Current assets$9.78B$7.11B$7.89B$6.25B$5.84B$6.63B$4.66B$4.33B$2.81B$3.25B
Total liabilities$2.52B$2.21B$2.04B$1.86B$1.60B$1.41B$1.45B$1.16B$996.40M$709.10M
Current liabilities$2.01B$1.75B$1.66B$1.42B$1.15B$965.20M$1.03B$820.60M$662.80M$596.50M
Total equity incl. NCI$17.94B$16.53B$13.40B$11.11B$11.95B$9.76B$8.28B$6.69B$4.78B$5.82B
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$1.84B$1.49B$1.22B$893.20M$587.10M$601.50M$595.50M$409.00M$241.20M$182.30M
Accounts receivable$1.53B$1.23B$1.13B$942.10M$782.70M$645.50M$645.20M$682.30M$507.90M$430.20M
Goodwill$370.30M$347.50M$348.70M$348.50M$343.60M$336.70M$307.20M$240.60M$201.10M$201.10M
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$255.10M$193.40M$188.70M$147.00M$121.20M$81.60M$123.50M$100.70M$82.50M$68.50M

Cash flow

INTUITIVE SURGICAL INC cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Operating cash flow$3.03B$2.42B$1.81B$1.49B$2.09B$1.48B$1.60B$1.17B$1.14B$1.09B
Capital expendituresUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Investing cash flow$665.80M-$3.27B-$360.10M$1.37B-$2.46B-$940.60M-$1.15B-$1.05B$378.70M-$1.28B
Financing cash flow-$2.36B$150.90M-$287.60M-$2.57B$43.00M-$85.70M-$168.40M$126.30M-$1.91B$514.40M
Net change in cash$1.34B-$707.70M$1.17B$294.70M-$332.50M$455.90M$273.20M$246.20M-$388.40M$322.00M
Stock-based compensation$788.20M$676.80M$592.80M$513.20M$449.20M$395.40M$335.80M$261.20M$209.10M$177.60M
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchases$2.30B$0$416.30M$2.61B$0$134.30M$269.50M$0$2.27B$42.50M
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Derived

INTUITIVE SURGICAL INC derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross margin66.0%67.5%66.4%67.4%69.3%65.6%69.4%69.9%70.2%69.9%
Operating margin29.3%28.1%24.8%25.3%31.9%24.1%30.7%32.2%33.9%35.1%
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenue7.8%8.1%8.3%8.2%7.9%9.1%7.5%7.0%6.7%6.6%
Current ratio4.87x4.07x4.76x4.40x5.08x6.86x4.53x5.28x4.24x5.45x
Revenue YoY growth20.5%17.2%14.5%9.0%31.0%-2.7%20.3%18.7%16.0%Unavailable
Net margin28.4%27.8%25.2%21.3%29.9%24.3%30.8%30.3%21.4%27.3%
R&D / revenue13.0%13.7%14.0%14.1%11.8%13.7%12.4%11.2%10.5%8.9%
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rate13.1%12.6%7.2%16.3%8.6%11.6%8.0%12.1%39.3%25.1%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ISRG in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-07-21View SEC filing
10-Q · Filed 2026-04-22View SEC filing
10-K · Filed 2026-02-03View SEC filing
10-Q · Filed 2025-10-22View SEC filing
10-Q · Filed 2025-07-23View SEC filing
10-Q · Filed 2025-04-23View SEC filing

Companies in the same industry

Reconciliation checks needing review

1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

balance equationreview2016-12-31

Difference 42700000 exceeds tolerance 6486900.000. Presentation or filing-vintage differences need review.